Endotoxins are physiologically present in portal venous blood.
1 2 If hepatic clearance is impaired, systemic endotoxinaemia may result (caused by portosystemic shunts, functional defects in the phagocytic capacity of the hepatic reticuloendothelial system, and decreased endotoxin binding capacity of whole blood [2] [3] [4] [5] ).
In spite of elevated serum cytokine and plasma endotoxin levels, 2 3 6-9 most patients with alcohol induced cirrhosis (AC) and chronic endotoxinaemia are not suVering from clinically evident systemic inflammatory reactions. This may be due to altered gene expression of cytokines, perhaps relating to endotoxin (for example, tolerance and sensitisation). 10 We recently reported enhanced mRNA expression of the proinflammatory cytokine tumour necrosis factor (TNF-) in unstimulated peripheral blood mononuclear cells (PBMC) from patients with advanced AC but did not elucidate the mechanisms which potentially (down) regulate the immune response in AC. 11 Interleukin 18 (IL-18; interleukin inducing factor) is a recently described peptide regulatory factor in the early host response to bacterial endotoxin (lipopolysaccharide (LPS)) which induces TNFproduction in PBMC. 12 13 In vitro, IL-18 gene expression was originally thought to be regulated constitutively with no increase or decrease on stimulation with LPS. 14 15 However, recent data showed that IL-18 expression was clearly detectable after LPS treatment. 16 17 Moreover, IL-18 modulates local cytokine production in response to LPS. 18 19 IL-18 is a key factor in the systemic inflammatory reactions in acute (Escherichia coli induced) endotoxaemiainflammatory reactions, which may be downregulated if IL-18 is neutralised. 20 This suggests that IL-18 may not only play a role as a marker of disease activity in patients with AC but may also have potential implications for therapeutic strategies in AC.
Hence the aim of this study was to investigate if IL-18 is involved in the immune response in patients with AC (who show no clinically evident signs of systemic inflammatory reactions) and to test the hypothesis that unstimulated PBMC from patients with AC are activated and contribute to gene expression of IL-18.
Patients and methods

PATIENTS
The study group consisted of 74 patients with confirmed AC (Child-Pugh stage A, n=18; Child-Pugh stage B, n=22; Child-Pugh stage C, n=34). 21 Forty three age and sex matched healthy individuals with no history of alcohol abuse and normal liver function tests served as controls (table 1) .
A diagnosis of AC was confirmed either histologically (n=55) or clinically (n=19) if biopsy was not available (for example, due to coagulopathy). A clinical diagnosis was established in patients demonstrating a Child-Pugh index >6 and signs of portal hypertension (endoscopically proved oesophageal varices; transjugularportocaval shunt). A previous history of daily ethanol intake of >80 g/day in men and >30 g/day in women for more than five years was requested.
Exclusion criteria were the presence of alcoholic hepatitis, autoimmune hepatitis, renal insuYciency (serum creatinine >115 µmol/l), or malignancy. Patients with an abstinence period of less than six months (that is, longer than in some comparable studies with abstinence periods of 1-2 months 8 ) were excluded (for example, patients with markers of recent alcohol abuse-namely, the presence of elevated carbohydrate deficient transferrin serum levels and/or early decrease in gamma glutamyl transpeptidase, as previously described 22 23 ) to avoid inclusion of patients with alcoholic hepatitis 24 if biopsy was not available. No patient suVered from active gastrointestinal bleeding or had overt signs of infection (fever, elevated white blood cell count).
mRNA expression of IL-18 was assessed in unstimulated PBMC in a subgroup of 14 (of 74) patients with histologically confirmed stable AC (Child-Pugh stage A, n=4; ChildPugh stage B, n=5; Child-Pugh stage C, n=5). 21 The study was approved by the university hospital ethics committee.
ISOLATION OF PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMC)
Peripheral venous blood (10-20 ml) was obtained from patients and healthy human volunteers by venepuncture and collected into heparinised, sterile, pyrogen free disposable syringes with endotoxin free heparin (10 U/ml).
PBMC were separated by standard density gradient centrifugation (Ficoll-Paque method; Biochrom, Berlin 25 ) and adjusted to 3×10 6 cells/ml in buVered RPMI 1640 supplemented with 10% (v/v) heat inactivated fetal bovine serum. For RNA extraction, cells were spun down at 1200 rpm and stored in 4 M GTC extraction buVer at −80°C.
IMMUNOASSAY FOR IL-18
Serum concentrations of IL-18 were determined in duplicate by a specific sandwich enzyme linked immunoassay (ELISA; Fujisaki Institute, Hayashibara Biochemical Laboratories, Inc., Okayama, Japan) with minor modifications. 26 27 Briefly, 96 well microtitre plates (Nunc Maxisorp, Denmark) were coated with 100 µl of the primary monoclonal antibody against IL-18 (2.5 µg/ml in phosphate buVered saline (PBS)) and incubated for three hours at room temperature. The coated plates were washed in PBS/Tween 20 buVer and blocked with 250 µl of 1% bovine serum albumin in PBS overnight at 4°C. Samples, diluted 1:5, and serial dilutions of the recombinant IL-18 standard, were added to the plates and incubated for two hours at 20°C.
After washing with PBS/Tween 20 buVer, 100 µl of peroxidase conjugated monoclonal detection antibody (working concentration 0.05 µg/ml) were added for three hours at room temperature. The enzyme reaction was developed using 100 µl of 10 mmol/l tetramethylbenzidine, 80 mmol/l H 2 O 2 , and 30 mmol/l potassium citrate (pH 4.1). After 15-20 minutes of incubation at room temperature, the reaction was terminated with 50 µl of 2 N H 2 SO 4 and optical density read at 450 nm (Emax Reader, MWG, Ebersberg, Germany; reference at 650 nm). Values were determined from a standard curve (range 8-500 pg/ml), constructed using serial dilutions of recombinant IL-18 standard, based on purified rabbit polyclonal anti-IL-18 conjugated with horseradish peroxidase. 4-Amino-antipyrine in potassium phosphate buVer was used as a substrate, and colour intensity was measured at 492 nm. The detection limit for this ELISA was 7.8 pg/ml with intra-and interassay variances of 5.8 (2.1) and 8.2 (2.4) respectively. The IL-18 specific ELISA showed no cross reactivity (for example, with other recombinant cytokines or cytokine receptors (IL-12, IL-2, interferon , IL-4, TNF-, and recombinant TNF receptors)) over a wide range of concentrations (0.1 pg/ml to 1 µg/ml).
RNA ISOLATION AND IL-18 REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION
(RT-PCR) ANALYSIS Unstimulated PBMC from 15 abstinent patients with liver cirrhosis were freshly isolated directly after Ficoll gradient separation. Total cellular RNA was extracted from isolated PBMC using an acid phenol-chloroform extraction method, as previously described. 28 RNA concentration was quantitated spectrophotometrically, and RNA degradation and purity were assessed by electrophoresis on a 1.5% agarose gel containing formaldehyde.
cDNA of PBMC was obtained by RT using 1 µg of RNA and oligo d (T) primers. PCR for IL-18 and glyceraldehyde 3-phosphate dehydrogenase (G3PDH) was performed in a final volume of 25 µl using 5 µl of cDNA on a thermal cycler (Perkin Elmer Cetus) for 35 cycles, each comprising 94°C for one minute, 55°C for one minute, with a further extension at 72°C for one minute. 25 Components of the PCR reaction were 10× PCR buVer (200 mM Tris HCl (pH 8.4), 500 mM KCl) and 10 mM dNTP mix (10 mM of each dATP, dCTP, dGTP, dTTP; Boehringer-Mannheim, Mannheim, Germany). Cytokine primer pairs were designed spanning exon-exon conjunctions and are therefore mRNA/cDNA specific and non-reactive with genomic DNA.
The following oligonucleotide primer sequences were used: IL-18 (amplification product 342 bp) up 5'GCT TGA ATC TAA ATT ATC AGT C, down 3'GAA GAT TCA AAT TGC ATC TTA T; G3PDH (amplification product 983 bp; Clontech Laboratories Inc., Palo Alto, USA) up 5'TGA AGG TCG GAG TCA ACG GAT TTG GT, down 3'CAT GTG GGC CAT GAG GTC CAC CAC. 15 The amplified products were separated by electrophoresis on a 2% agarose gel and visualised by UV light illumination using ethidium bromide staining.
A 100 bp DNA ladder was run in parallel as a molecular size marker. Densitometric assessment of PCR products was performed using EASY Plus 3.2 software (Herolab, Wiesloch, Germany).
Semiquantitative PCR results were generated by grading a ratio between the densitometry results of the target cytokine and the housekeeping enzyme (for example, the ratio of IL-18 mRNA divided by G3PDH).
ENDOTOXIN ASSAY
Plasma endotoxin levels were determined using an automated kinetic turbodimetric limulus amoebocyte lysate microtitre test with individual internal standardisation as previously described. 29 30 An endotoxin reference curve was established in each sample by spiking 50 µl of each of the samples (diluted 1:5 and heated at 80°C) with 25 µl of LPS to obtain 2500, 500, 50, 5, 0.5, 0.05, and 0 pg/ml of LPS. LPS NP 3 (Novo Pyrexal, Weidner, Waldorf, Germany; 100 pg NP3=1 EU EC-5, FDA) was used. Then 25 µl of lysate were added (Weidner). The increase in optical density was measured at 37°C at 30 second intervals for 100 minutes at 405 nm. The sensitivity of the assay was 0.1 pg/ml. 30 
SOLUBLE CD14 ASSAY
Serum concentrations of soluble CD14 were determined using a commercially available ELISA according to the manufacturer's specifications (IBL, Hamburg, Germany).
STATISTICAL ANALYSIS
Non-parametric tests were used to analyse the results of IL-18. In particular, the MannWhitney U test was used to compare data between the two groups and the Kruskal-Wallis Moreover, both serum levels of CD14 (fig 2)  and plasma levels of LPS (fig 3) in patients with AC were significantly elevated in Child-Pugh stages B and C (p<0.001) compared with healthy controls (p<0.001).
Analysis by Spearman rank correlation showed a significant correlation between serum levels of IL-18 and CD14 (r=0.47, p<0.001) (fig 4) and a weak correlation with corresponding plasma levels of LPS (r=0.26; p<0.05; data not shown).
EXPRESSION OF HUMAN IL-18 DETECTED BY
RT-PCR
Semiquantitative RT-PCR showed no diVerence between mRNA expression of IL-18 in unstimulated PBMC of patients with AC (n=14) of Child-Pugh stages A (n=4) and B (n=5) compared with five healthy controls. In contrast, enhanced mRNA expression of IL-18 was found in unstimulated PBMC of patients with AC of Child-Pugh stage C (n=5) compared with both healthy controls (n=5; p<0.01) and Child-Pugh stage A (n=4; p<0.01) (fig 5A, B) .
Results of Spearman rank correlation analysis demonstrated a significant correlation between mRNA expression of IL-18 in unstimulated blood mononuclear cells of patients with AC (n=14) and both sCD14 (r=0.72; p<0.01) ( fig 6A) and plasma LPS (r=0.76; p<0.01) (fig 6B) . IL-18 (pg/ml) Recent in vitro data show that endotoxin (LPS) stimulates IL-18 mRNA expression of PBMC. 16 20 31 32 Our in vivo data demonstrate a significant correlation between endotoxin (LPS) plasma (and CD14 serum) levels and IL-18 mRNA expression of unstimulated PBMC. These strongly positive correlations suggest presensitisation of PBMC in the circulation of patients with AC by endotoxin. The term "unstimulated" may therefore be misleading in patients with AC.
Figure 5 (A) mRNA expression of human interleukin 18 (IL-18) in unstimulated freshly isolated peripheral blood mononuclear cells of patients with alcohol induced cirrhosis (Child's stage A-C; n=14) compared with healthy controls (n=5
Recent in vitro data showed that 1 µg/ml of pure LPS (in the absence of CD14) stimulated IL-18 mRNA expression in mouse macrophage-like cells. 17 CD14 dependent in vitro stimulation of mononuclear blood cells by LPS was shown to occur with even lower LPS concentrations (1 ng/ml LPS). 33 These endotoxin concentrations may also occur in portal venous blood (endotoxin concentrations of 100 pg/ml to 1 ng/ml 1 ) and sensitise PBMC in vivo. Further investigations are needed to define the exact mechanisms and localisation of sensitisation of PBMC in vivo (for example, portal blood v low endotoxin concentrations encountered in peripheral blood from patients with AC of Child-Pugh stage C (5.0 (1.8) pg/ml; range 0-63)) and the possible additional enhancing or inhibiting factors. 34 Preliminary data based on mRNA expression of IL-18 in unstimulated PBMC of six patients with (hepatitis C) virus induced cirrhosis (n=6; Child-Pugh stage A=3; C=3) suggest that endotoxin dependent sensitisation of PBMC may be more specific to cirrhosis per se and reduced hepatic clearance than to the aetiology of the disease (unpublished data).
Ethanol aVects the production of proinflammatory cytokines such as TNF-. 35 36 To avoid direct ethanol eVects, we excluded patients with an abstinence period of less than six months and histological or biological markers of alcoholic hepatitis (thus longer than in comparable studies with abstinence periods of 1-2 months). 37 Previous studies repeatedly reported a close relationship between elevated circulating plasma levels of proinflammatory cytokines (for example, TNF-) and the severity of AC. 7 38 We have demonstrated for the first time a close relationship between elevated plasma levels of IL-18 and Child-Pugh stage of the disease. Even if IL-18 serum levels of cirrhotics may be supposed to reflect impaired hepatic clearance (as previously discussed for other cytokines 6 39 ) increased cytokine serum levels encountered in peripheral venous blood are believed to be derived at least partially from PBMC. However, preliminary ELISA data based on 22 patients with hepatitis C virus induced cirrhosis (Child-Pugh stage A, n=11; Child-Pugh stage B, n=4; Child-Pugh stage C, n=7) led us to the conclusion that elevated IL-18 serum levels in severe AC are more specific to cirrhosis per se than to the aetiology of the disease.
Concentrations of LPS measured in patients with AC were comparable with cell free plasma endotoxin levels reported in the literature. 7 9 29 30 40 The rather weak correlations between plasma LPS and serum IL-18 protein levels are not surprising for at least two reasons: firstly, portosystemic shunting is known to result in repetitive peaks of endotoxinaemia and not in a constant high endotoxinaemia. Secondly, IL-18 protein production is mostly regulated constitutively (not inducibly).
In conclusion, enhanced expression of IL-18 in unstimulated PBMC supports the assumption that IL-18 is involved in the inflammatory response of PBMC in patients with AC. Together with recent in vitro data in human PBMC from healthy individuals, it may be suggested that gut derived bacterial endotoxin is involved in enhanced gene expression of IL-18. 16 31 Although semiquantitative RT-PCR is thought to be appropriate for analysing cytokine mRNA, 13 41-44 data should be confirmed by quantitative PCR.
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